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Abstract A yeast two-hybrid screen revealed that regulatory
subunits (RII) of PKAII bind the Yotiao protein. Yotiao
interacts with the NR1 subunit of the NMDA receptor. A
purified C-terminal fragment of Yotiao binds PKAII, via an RII
binding site constituted by amino acid residues 1452^1469, with a
dissociation constant (Kd) between 50 and 90 nM in vitro. A
stable complex composed of Yotiao, RII and NR1 was
immunoprecipitated from whole rat brain extracts. Immuno-
staining analysis disclosed that Yotiao, RIIL and NR1 colocalize
in striatal and cerebellar neurons. Co-assembly of Yotiao/PKAII
complexes with NR1 subunits may promote cAMP-dependent
modulation of NMDA receptor activity at synapses, thereby
influencing brain development and synaptic plasticity.
z 1999 Federation of European Biochemical Societies.
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1. Introduction
Phosphorylation of intracellular substrates by protein kin-
ases conveys signals generated at the plasma membrane to
regulatory molecules that control multiple cell functions [1].
Serine/threonine protein kinases and phosphatases are often
targeted to speci¢c subcellular locations by anchor proteins
[2^4]. Anchored PKAII is implicated in the regulation of
certain ion channel activities, hormone secretion, sperm
motility and cAMP-regulated gene transcription [2^8]. Fur-
thermore, expression of a mitochondrion-associated AKAP
(AKAP121) is markedly induced by cAMP [9]. This suggests
that hormones may di¡erentially control the distribution of
cAMP signals to speci¢c intracellular sites by altering the
concentration of an AKAP. Some AKAPs (e.g. AKAP79)
are thought to be multifunctional proteins that bind several
signaling molecules (protein kinase C, calcineurin, PKAII)
thereby integrating information from multiple regulatory in-
puts [3].
N-methyl-D-aspartate (NMDA) receptors are expressed
throughout the mammalian central nervous system. They me-
diate excitatory synaptic transmission and may be involved in
brain development, excitotoxicity, learning and memory [10].
NMDA receptors are pentameric proteins composed of one or
two NR1 subunits and a subset of NR2 A-D subunit isoforms
[10]. Molecular diversity of NMDA receptors is further in-
creased by the existence of numerous NR1 splice variants
[10]. Critical physiological and functional properties of the
receptor are contributed principally by NR1 subunits [10].
Cyclic AMP stimulates NMDA receptor-mediated currents
and Ser897 in NR1 is a good target site for PKA-catalyzed
phosphorylation [11^13].
Yotiao is a coiled coil protein that is expressed in mamma-
lian brain and accumulates near neuromuscular junctions [14].
It interacts with the C1-exon speci¢c splice variant of NR1
and forms a protein complex with the NMDA receptor in
vivo.
We now identify Yotiao as an AKAP that binds and targets
PKAII to a microenvironment that contains the NR1 subunit
of the NMDA receptor. Enrichment of PKAII in proximity
with clustered NR1 (and NMDA receptors) would increase
the sensitivity of a critical target/e¡ector to regulation by lo-
cally generated cAMP.
2. Materials and methods
2.1. Yeast two-hybrid screening
Mouse full-length RIIK cDNA was cloned in the yeast bait plasmid
pBD-Gal4 (Stratagene). The corresponding cDNA encodes a fusion
protein with the DNA binding domain of Gal4 fused to the NH2-
terminus of RIIK. Approximately 1U106 clones were screened via the
two-hybrid interaction assay, using a rat thyroid cDNA library cloned
in the yeast expression vector pBD-Gal4 (Stratagene) [9]. Auxotrophic
yeast clones growing on selective medium lacking Leu, Trp and His
were isolated and tested for L-galactosidase activity.
2.2. Expression of recombinant proteins in Escherichia coli and RII
binding analysis
Amino-terminal truncations of the protein encoded by RBP64
cDNA were generated by polymerase chain reaction using speci¢c
oligonucleotide primers. Recombinant proteins were expressed in
E. coli BL-21(DE3). The hexahistidine (H6)-tagged fusion pro-
teins were puri¢ed as previously described [4]. A peptide derived
from the K-helical wheel of Yotiao protein was synthesized:
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1450ERLEEEIAKVIVSMSIAFAQQTE1472-amide. A mutated peptide
with Ala1457sPro and Val1459sPro was also synthesized (Primm,
Italy). RII binding assays were carried out as previously described [4].
2.3. Antibodies, immunoblotting and immunoprecipitation
Rabbits were immunized with a His-tagged fusion protein of
RBP64. Immune serum (anti-Yotiao) was used at the following dilu-
tions: Western blot (1/1000), immunoprecipitation (1/200) and immu-
nostaining (1/1600). Rabbit anti-RII polyclonal antibodies were pre-
viously described [4]. For immunoprecipitation experiments, a mixture
of anti-RIIK and anti-RIIL polyclonal antibodies was used. Rat brain
and synaptosomal membrane proteins from whole rat brain were
prepared as described [14]. Protein kinase A assays were performed
as described [6].
2.4. Northern gel analysis
Total RNA was extracted from rat tissues as previously described
[7].
2.5. Immuno£uorescence
Cerebellum sections from Sprague Dawley rats (4 weeks of age) and
rat primary striatal neurons were double stained with anti-RIIL or
anti-Yotiao polyclonal antibodies and monoclonal antibodies against
NR1 were carried out as described [6].
3. Results
A cDNA library derived from rat thyroid mRNAs was
inserted into the yeast vector pGAD10 and screened by using
as ‘bait’ a cDNA encoding a full-length RII in the yeast plas-
mid, pGBD10 (pGBD-RII) (Fig. 1A). The interaction screen
yielded multiple isolates of di¡erent types of cDNAs. One
clone was isolated and named RBP64. Coexpression of
pGAD-RBP64 with pGBD-RII vectors in yeast strongly acti-
vated transcription of the His reporter gene (Fig. 1B). The
open reading frame of RBP64 cDNA clone is 1182 bp in
length and encodes a 394 amino acid polypeptide. Sequence
and Southern blot analyses indicate that RBP64 cDNA is a
portion of the rat homolog of human Yotiao cDNA, corre-
sponding to the region 3904^5086 bp [14]. Yotiao belongs to a
multiple spliced family of proteins coded by a single gene
sequence and binds the C1-exon speci¢c splice variant of the
NR1 subunit of NMDA receptors [14,15]. RBP64 cDNA de-
tected an 11 kb mRNA in brain and heart, which corresponds
to the size of the Yotiao transcript [14]. Yotiao is also ex-
pressed in testes, thyroid and a thyroid-derived cell line
(FRTL-5, 9) (Fig. 1C). Yotiao contains a putative RII binding
site, common to all AKAPs. Amino acids with large aliphatic
side chains that are essential for high a⁄nity binding of RII
appear at the same positions in Yotiao, AKAP75 and
AKAP120 proteins [16,17]. Deletion mutagenesis of the clone
RBP64 cDNA was employed to map the RII binding site.
cDNA fragments including all or part of the putative RII
binding site were subcloned in the pRSET-A plasmid and
recombinant His-tagged fusion proteins were expressed in
E. coli. RII overlay binding assays disclosed that residues
202^219 of the RBP64 protein (residues 1452^1469 of human
Yotiao) mediate RII binding (Fig. 2B,C). Two recombinant
fragments of RBP64 were tested in the ligand-blot analysis by
probing denatured electroblots with [32P]-RIIL, in the pres-
ence or absence of unlabelled RIIL. As shown in Fig. 2D,
unlabelled RIIL inhibited [32P]-RII binding in a dose-depen-
dent manner. The results demonstrated that recombinant frag-
ment of rat Yotiao binds RII, with a Kd ranging between 50
and 90 nM for both recombinant fragments in vitro. To fur-
ther analyze the a⁄nity between RII and Yotiao, a synthetic
peptide spanning the RII binding site of human Yotiao was
used in a competition curve with [32P]-RIIL and RBP64-2F
recombinant fragment. Fig. 2D shows that the peptide com-
peted the binding of [32P]-RIIL to RBP64-2F with an ap-
parent IC50 between 70 and 150 nM. A synthetic peptide
mutated in Ala1457sPro and Val1459sPro, that disrupt the
amphipathic helix, did not compete the binding of [32P]-RIIL
to RBP64-2F recombinant polypeptide [3].
Immunoprecipitation of Triton X-100 solubilized mem-
brane proteins from whole rat brain with anti-RII antibody
resulted in the co-isolation of Yotiao (Fig. 3A). Anti-RII or
anti-Yotiao antibody also e⁄ciently co-precipitated NR1 sub-
unit (Fig. 3B). The results suggest that Yotiao, NR1, and RII
Fig. 1. Identi¢cation of a cDNA clone (RBP64) that interacts with
the PKA regulatory subunit, RII, in a yeast two-hybrid system.
A: 200 ng of His-tagged RII puri¢ed protein (lane 1) or total pro-
tein extracts (100 Wg) from control YRG-2 yeast strain (lanes 4, 5)
or from YRG-2 cells expressing recombinant pGBD-RII fusion pro-
tein (lanes 2, 3) were loaded on a 10% SDS-PAGE gel and immu-
noblotted with anti-RIIK polyclonal antibodies. B: YRG-2 cells
were co-transformed with the indicated yeast expression vectors and
grown for 2 days on selective plates. A histidine analog 3-aminotria-
zole (3-AT) was added to His-plates. C: Total RNA (20 Wg) from
several rat tissues was size-fractionated on a 0.9% agarose gel, trans-
ferred to an N-Hybond ¢lter and hybridized with 32P-labelled
RBP64 cDNA probe.
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interact in a stable manner in vivo. Immunoprecipitation of
either Yotiao or NR1 from whole rat brain resulted in a
7.3 þ 1.2- and 6.9 þ 1.9-fold enrichment of cAMP-dependent
protein kinase activity in the immune complexes over the con-
trol serum. Kinase A activity was fully inhibited by a speci¢c
PKA inhibitor peptide (PKI), demonstrating that NR1/Yotiao
interact in vivo with the kinase. We estimate that PKA activ-
ity immunoprecipitated from whole rat brain with NR1 or
Yotiao antibodies represents about 1.2 þ 0.3% of the total
PKAII immunoprecipitated with anti-RII antibodies (Fig.
3C). PKA activity recovered in the immunoprecipitates of
NR1 or Yotiao of synaptosomal membranes is enriched 3^
4-fold compared to that of whole rat brain (Fig. 3D). These
Fig. 2. Characterization of the RII binding site of Yotiao. A: Ami-
no acid sequence alignment of the RII binding regions of two
AKAPs with the putative RII binding sites of human Yotiao
(hYotiao, residues 1452^1469) and that derived from the rat homo-
log (rYotiao, residues 202^219 of the clone RBP64). In bold are the
conserved hydrophobic residues essential for RII binding activity.
B: His-tagged recombinant proteins of the rat clone RBP64 were
size-fractionated by SDS-PAGE, transferred to Immobilon P and
blotted with full-length 32P-labelled RIIL. C: Total protein (T) or
100 ng of a⁄nity puri¢ed RBP64 fragments (P) from E. coli ex-
pressing the RBP64-2F or RBP64-6F deletion mutants, were immu-
noblotted with anti-Xpress (Invitrogen) polyclonal antibodies (left
panel) or ligand-blotted with 32P-labelled RIIL (right panel). D: Left
panel: Electroblots containing 100 ng of either RBP64-2F (open
circles) or RBP64-4F (closed circles) were probed with 32P-labelled
RIIL in presence or absence of increasing concentrations of unla-
belled RIIL protein. Right panel: The RII binding of RBP64-2F
fragment was analyzed using 32P-labelled RIIL preincubated with in-
creasing concentrations of synthetic peptide spanning the K-helical
RII binding site of the human Yotiao (open circles) or with a mu-
tant peptide (close circles). Inset: Immunoblots containing 100 ng of
recombinant RBP64-2F peptide were probed with [32P]-RIIL in the
absence (A) or presence (B) of 5 WM of Yotiao peptide (residues
1450^1472).
Fig. 3. RII and Yotiao coimmunoprecipitate with NR1. A: Total
proteins (6 mg) extracted from whole rat brain were immunoprecipi-
tated with anti-RII (K and L) or anti-Yotiao antibody. Immunopre-
cipitates (IP) and 400 Wg of proteins from whole rat brain (WB)
were immunoblotted with anti-Yotiao antibody. B: Detection of
NR1 in the immunoprecipitates of Yotiao or RII immunoblotted
with a⁄nity puri¢ed anti-NR1 monoclonal antibodies. C, D: PKA
activity of immunoprecipitates from rat brain. Total proteins (2 mg)
were solubilized with Triton X-100 from either whole rat brain or
synaptosomal membranes and subjected to immunoprecipitation ei-
ther with anti-Yotiao (KY), anti-NR1 (KNR1), anti-RII (KRII) or
pre-immune sera (C). PKA activity on immunoprecipitates was as-
sayed in absence or presence of a PKA speci¢c inhibitor (PKI).
Where indicated, 500 ng of recombinant Yotiao polypeptide (Yrec)
were added to brain extracts before immunoprecipitation. The data
represent a mean of four independent experiments þ S.E.M.
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data suggest that the complex PKAIIWYotiaoWNR1 accumu-
lates speci¢cally in synaptosomes. The addition of recombi-
nant fragment of rat Yotiao to synaptosomal membrane ex-
tracts increased 12.5 þ 1.8-fold the cAMP-dependent kinase
activity in the anti-Yotiao immunoprecipitates over the con-
trol serum. These ¢ndings indicate that Yotiao is limiting in
vivo.
RIIL and PKAIIL are concentrated in the soma and den-
drites of many types of neurons in olfactory bulb, basal gan-
glia, striatum, cerebral cortex, and other forebrain regions
[18]. Yotiao is especially abundant in the soma and the den-
dritic arborizations of Purkinje cells, but the protein is also
evident in neurons in most regions of the mammalian brain.
The localization of Yotiao partly overlaps with that of NR1
[14]. To determine the distribution of Yotiao, RIIL and NR1
in situ, sections of 4 weeks old rat cerebella were analyzed by
immuno£uorescence staining. Sections were probed with both
monoclonal anti-NR1 and polyclonal anti-Yotiao antibodies
or with monoclonal anti-NR1 and polyclonal anti-RIIL anti-
bodies (Fig. 4A). The £uorescence signals indicate that NR1
colocalizes with Yotiao in cell bodies and dendritic arboriza-
tions of Purkinje cells. RIIL is likewise concentrated in cell
bodies and dendrites and the distributions of RIIL and NR1
partially overlap. The intracellular distributions of Yotiao and
RIIL are also similar. Furthermore, double immuno£uores-
cence analysis revealed that Yotiao and NR1 immunoreactiv-
ity had overlapping staining patterns in the soma and den-
drites of striatal neurons (Fig. 4B). RIIL signal on the other
hand overlaps only partially since it is present in other local-
izations inside the cell (Fig. 4).
4. Discussion
We have shown that Yotiao binds RII with high a⁄nity
and interacts in vivo with PKAII. Thus, Yotiao may serve as
a sca¡olding protein, anchoring PKA holoenzyme close to the
NMDA receptor. The ability to sequester PKAII and co-lo-
calization with RII and NMDA receptors in neurons in situ
suggest that Yotiao mediates incorporation of the anchored
kinase into multi-component signaling modules. Our data
complement a recent report showing that PKA and a phos-
phatase are present in the same complex in vitro with the
NMR1 subunit, but the trimeric complex in vivo and the
a⁄nity of Yotiao and PKA have not been determined [19].
NMDA receptors are multimeric proteins that directly cou-
ple with calmodulin, calmodulin-activated protein kinase II,
SynGAP and other cytoskeleton-associated adapter proteins
that assemble and organize clusters of receptors. The nature
and stoichiometry of proteins associated with NMDA recep-
tors may markedly modulate receptor functions [20,21]. Ion
Fig. 4. Immuno£uorescence analyses of Yotiao, RIIL and NR1. A: Cerebellum sections were probed with either anti-Yotiao or anti-RIIL poly-
clonal antibodies and monoclonal antibodies against NR1. Confocal microscopy was used to collect £uorescence signals after application of sec-
ondary antibodies tagged with £uorescein isothiocyanate or rhodamine. Size bar: upper panels, 45 Wm; lower panels, 22 Wm. B: Rat primary
striatal neurons were probed with anti-Yotiao polyclonal antibodies or anti-RIIL and monoclonal antibodies against NR1. Fluorescein isothio-
cyanate (Yotiao and RIIL) or rhodamine (NR1) £uorescent signals were collected: a composite of two images (Yotiao/NR1 and RIIL/NR1) is
also shown. In control panels, the ¢rst antibodies (anti-Yotiao or anti-RIIL) were preincubated with excess of Yotiao or RIIL recombinant pro-
teins, respectively.
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currents elicited by NMDA agonists are potentiated by cAMP
analogs and forskolin [10,22]. Moreover, PKA e⁄ciently
phosphorylates Ser897 in NR1 in vitro and in vivo [13]. How-
ever, PKA also promotes NR1 phosphorylation at several
sites (including Ser899, Ser890) by activating DARPP-32, an
inhibitor of protein phosphatase 1 [23]. In addition, protein
kinase C-mediated phosphorylation of Ser889 and Ser890 in
NR1 regulates the clustering of NMDA receptors [13,24]
and inhibits binding of calmodulin (a channel inhibitor) to
the C-terminus of NR1 [21]. Thus, the precise role of PKA-
catalyzed phosphorylation in the regulation of NMDA recep-
tor functions remains to be elucidated.
We propose that the complex formed in the membrane
containing PKAII, functions as a ‘transduceosome’ by physi-
cally transmitting the signals from cAMP/PKA to the NMDA
receptor via Yotiao. Yotiao-mediated association of PKAII
with post-synaptic NMDA receptors could have a variety of
fundamentally important consequences. Activation of anch-
ored PKAII might (a) directly alter NMDA channel activity
in the context of a multi-protein e¡ector complex; (b) modu-
late the clustering of receptors; (c) promote or inhibit recruit-
ment of other proteins that interact with and regulate the
receptor/channel; or (d) promote phosphorylation of co-local-
ized AMPA receptors, which are an established target for
anchored PKA.
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